LAVA Therapeutics NV (LVTX) Live Stock Price, Forecast & News | FX Empire

Advertisement

Advertisement

LAVA Therapeutics NV
LVTX
(Nasdaq - US)
N/A
2.85
-0.05 (-1.72%)
in:usd•As of: Apr 30, 2024 15:59 UTC -4
Open
2.88
High
2.96
Low
2.85

Stats

Prev. Close

2.90

Open

2.88

Day's Range

2.85 - 2.96

52 Week Range

1.13 - 6.47

YTD Change

80.38%

1 Year Change

88.74%

Market Cap

N/A

P/E Ratio

N/A

Volume

3,895.00

Beta

0.64

Sector

Health Technology

Industry

Economic CalendarAll Events

Time zone: GMT

Tuesday, April 30th 2024
Time	Currency	Event	Impact	Actual	Consensus	Previous
13:00	USD	S&P/Case-Shiller Home Price MoMFeb	Medium	0.9%	0.6%	-0.1%
13:45	USD	Chicago PMIApr	Medium	37.9	45	41.4
14:00	USD	CB Consumer ConfidenceApr	Medium	97.0	104.0	103.1
20:30	USD	API Crude Oil Stock ChangeApr/26	Medium	4.906M		-3.23M

Wednesday, May 1st 2024
Time	Currency	Event	Impact	Actual	Consensus	Previous
12:15	USD	ADP Employment ChangeApr	Medium		175K	184K
12:30	USD	Treasury Refunding Announcement	Medium
13:45	USD	S&P Global Manufacturing PMI FinalApr	Medium		49.9	51.9

Latest News

featured

Zacks Investment ResearchAug 22, 2023

LAVA Therapeutics N.V. (LVTX) Reports Q2 Loss, Tops Revenue Estimates

LVTX-1.72%

featured

Zacks Investment ResearchJun 15, 2023

Lava (LVTX) Discontinues Hematological Tumor Study, Shares Fall

LVTX-1.72%

featured

Zacks Investment ResearchJun 2, 2023

LAVA (LVTX) Up on J&J's (JNJ) Cancer Study Candidate Selection

LVTX-1.72%

featured

Zacks Investment ResearchNov 25, 2022

Can LAVA Therapeutics N.V. (LVTX) Climb 198% to Reach the Level Wall Street Analysts Expect?

LVTX-1.72%

featured

Zacks Investment ResearchNov 16, 2022

LAVA Therapeutics N.V. (LVTX) Q3 Earnings Surpass Estimates

LVTX-1.72%

featured

Zacks Investment ResearchNov 14, 2022

Will LAVA Therapeutics N.V. (LVTX) Report Negative Q3 Earnings?

LVTX-1.72%

Data Vendor: Xignite Logo

Stocks

Loading

Loading

Trade With A Regulated Broker